Liveraid Capsule

Overview Liveraid Capsule

Liveraid Capsules offer a novel blend of Silymarin, alpha-lipoic acid, selenium, and L-ornithine-L-aspartate (LOLA). Silymarin aids in liver cell regeneration following alcohol or drug-induced damage, promoting liver decongestion. This decongestant effect enhances bile flow, mitigating stagnation, gallstone formation, and bile-related liver injury. Furthermore, it may improve survival rates in cirrhosis patients, support viral hepatitis treatment, and offer protection against industrial toxins. LOLA enhances ammonia detoxification in the liver and other organs, proving beneficial for individuals with cirrhosis and hepatic encephalopathy. Alpha-lipoic acid's antioxidant properties reduce hepatic fibrosis resulting from liver damage, suggesting potential in cirrhosis treatment. Its fat solubility facilitates cellular penetration for optimal therapeutic efficacy. Professional medical guidance is essential.